Global Pulmonary Endoscopy Devices Market Size By Type (Rigid Endoscopy Devices, Flexible Endoscopy Devices), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Pulmonary Endoscopy Devices Market was valued at USD 1.9 billion in 2023 and is projected to reach USD 3.4 billion by 2031, expanding at a CAGR of 7.5% during the forecast period from 2023 to 2031. This growth is driven by the rising prevalence of respiratory diseases, including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. Increasing awareness about early diagnosis, coupled with technological advancements in minimally invasive procedures, has significantly propelled the demand for pulmonary endoscopy devices globally.

Drivers:

1. Increasing Prevalence of Respiratory Diseases:

The growing incidence of respiratory disorders, particularly among the aging population, is a major factor boosting the adoption of pulmonary endoscopy devices. Early and accurate detection of conditions such as lung cancer and bronchitis is crucial, thereby driving demand.

2. Technological Advancements in Endoscopic Imaging:

Innovations in high-definition imaging, narrow-band imaging, and endoscopic ultrasound are enhancing diagnostic accuracy and clinical outcomes, leading to greater adoption across healthcare settings.

3. Rising Demand for Minimally Invasive Procedures:

Patients and clinicians are increasingly opting for procedures that offer quicker recovery and reduced complications. Pulmonary endoscopy fits this demand, making it a preferred diagnostic and therapeutic tool.

Restraints:

1. High Cost of Endoscopy Devices and Procedures:

The cost of acquiring and maintaining advanced pulmonary endoscopy systems can be prohibitive, especially for smaller healthcare institutions and in developing regions.

2. Shortage of Skilled Professionals:

The operation of pulmonary endoscopy devices requires specialized training. A shortage of trained endoscopists and technicians remains a challenge for widespread adoption.

Opportunity:

1. Emerging Markets Expansion:

Countries in Asia-Pacific and Latin America present significant opportunities due to increasing healthcare infrastructure, rising disposable income, and growing awareness about respiratory health.

2. Integration of AI and Robotics:

Artificial intelligence is being incorporated into endoscopic imaging to enhance diagnostic precision. Robotics-assisted bronchoscopies are also becoming more common, opening new avenues for clinical applications and growth.

Market by System Type Insights:

By system type, flexible bronchoscopes dominated the market in 2023 due to their versatility and reduced patient discomfort. However, the endobronchial ultrasound (EBUS) systems segment is anticipated to grow at the fastest rate, driven by its ability to access hard-to-reach lymph nodes for diagnostic biopsies with high precision.

Market by End-use Insights:

Hospitals remained the largest end-user segment in 2023, accounting for over 50% of the revenue share. This is attributed to the availability of advanced infrastructure and skilled healthcare professionals. Meanwhile, ambulatory surgical centers (ASCs) are expected to witness rapid growth, driven by their cost-effective and convenient procedural offerings.

Market by Regional Insights:

North America led the global pulmonary endoscopy devices market in 2023, supported by a robust healthcare system, high healthcare spending, and early adoption of new technologies. Asia-Pacific is forecast to experience the highest CAGR during 2023–2031, fueled by increasing healthcare investments and a growing patient pool suffering from respiratory ailments.

Competitive Scenario:

Key players in the market include Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, Medtronic plc, Karl Storz SE & Co. KG, and Ambu A/S. These companies are focusing on technological innovation, product launches, and strategic collaborations to strengthen their market share.

Notable Developments:

2023: Olympus launched an advanced bronchoscope series integrated with AI-assisted navigation.

2024: Boston Scientific acquired a respiratory diagnostics start-up to enhance its pulmonary health portfolio.

2025: Ambu A/S introduced a next-gen single-use bronchoscope optimized for intensive care units (ICUs) and emergency departments.

Scope of Work – Global Pulmonary Endoscopy Devices Market

Report Metric Details

Market Size (2023) USD 1.9 Billion

Projected Market Size (2031) USD 3.4 Billion

CAGR (2023–2031) 7.5%